Therapeutic target discovery using Boolean network attractors: avoiding pathological phenotypes
Arnaud Poret (LBBE), Jean-Pierre Boissel

TL;DR
This paper introduces an algorithm that uses Boolean network attractors to identify therapeutic targets by removing pathological phenotypes, demonstrated on cancer and Fanconi anemia models, aiding drug discovery.
Contribution
It presents a novel in silico method for target identification that links Boolean network attractors to phenotypes, enabling the removal of disease-associated attractors.
Findings
Successfully removed pathological attractors in models
Identified target combinations for disease phenotypes
Supports computational approach to drug target discovery
Abstract
Target identification, one of the steps of drug discovery, aims at identifying biomolecules whose function should be therapeutically altered in order to cure the considered pathology. This work proposes an algorithm for in silico target identification using Boolean network attractors. It assumes that attractors of dynamical systems, such as Boolean networks, correspond to phenotypes produced by the modeled biological system. Under this assumption, and given a Boolean network modeling a pathophysiology, the algorithm identifies target combinations able to remove attractors associated with pathological phenotypes. It is tested on a Boolean model of the mammalian cell cycle bearing a constitutive inactivation of the retinoblastoma protein, as seen in cancers, and its applications are illustrated on a Boolean model of Fanconi anemia. The results show that the algorithm returns target…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
